Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®

Published: 04.08.2022

Navamedic ASA: Trading Update

Published: 04.07.2022

Navamedic ASA: Minutes of Annual General Meeting

Published: 02.06.2022

Navamedic ASA completes acquisition of Impolin AB and issues consideration shares

Published: 01.06.2022

Navamedic ASA: Q1 2022 financial results

Published: 10.05.2022

Navamedic ASA acquires Impolin AB and bolsters its product portfolio

Published: 05.05.2022